All Comments by
- Anne Fagan on Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.
- Andrew Quest on Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein.
- Costantino Iadecola on Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.
- Brian Bacskai on Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.
- Eli Kammerman on The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
- Felicia Y.T. Teng on Is ALS Role a Go for Nogo-A?
- Terrence Town on Death by Glia?—Chemokine Receptor Nudges Neuron Loss in AD Mice
- Richard Ransohoff on Death by Glia?—Chemokine Receptor Nudges Neuron Loss in AD Mice
- Matteo Fossati on Is ALS Role a Go for Nogo-A?
- Shaohua Xu on Keystone: Tau, Huntingtin—Do Prion-like Properties Play a Role in Disease?
- Andrew Doig on Synuclein Modifications: Caveat Emptor With Those Phosphomimetics
- Felix Hernandez on Early Casualty, Neurogenesis Cripples Cognition in AD Mice
- Roberta Diaz Brinton on Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease.
- Richard Powers on Hospital characteristics associated with feeding tube placement in nursing home residents with advanced cognitive impairment.
- Angele Parent on Forgetting is regulated through Rac activity in Drosophila.